Upgrade

BioRestorative Therapies, Inc.

BRTX

Last
$1.90
Day
+0.5%
1y
-94.3%
5y
+2679.4%
52w
-94.5%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1131d
EMA 21
2.49
EMA 50
3.37
EMA 200
9.03
20d high
-35.5%
5y high
-99.4%
5y range
1th
Website · 13 employees · United States

Positions held

Your positions

BRTX isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-6
Hold
avoid
Signal
Sell
Target
$2.38
Stop
$1.48
Stop distance
22.1%
Target vs last
+25.3%

Fundamentals

Market cap$2.61MEnterprise value-$1.16MTrailing P/E—Forward P/E-0.18
PEG—Price / book0.80Beta0.85Dividend yield0.00%
Revenue growth-7.3%Earnings growth—Gross margin92.1%Operating margin-146.1%
Profit margin0.0%ROE-2.4%ROA-118.8%Debt / equity0.01
Current ratio2.35Free cash flow-$9.71MAnalyst recommendationbuyMean target$300.00
52w high$34.4052w low$1.75

Quarterly

2026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.3M$0.0M
Op margin-14612.6%-19516.8%-31432.3%-1089.8%-19230.1%
Net income-$2.2M-$3.2M-$3.0M-$2.7M-$5.3M
Gross margin68.1%91.7%10.4%97.1%88.4%
Gross profit$0.0M$0.0M$0.0M$0.3M$0.0M
Operating income-$3.4M-$3.8M-$3.7M-$3.3M-$4.8M
  • Revenue +18% vs prior quarter ($0.0M vs $0.0M).
  • Gross margin 68.1% (was 91.7% prior quarter).
  • Operating margin expanded to -14612.6%.

Yearly (6y)

20252024202320222021
Revenue$0.4M$0.4M$0.1M$0.1M—
Op margin-4350.1%-2881.6%-10382.3%-15745.8%—
Net income-$14.2M-$9.0M-$10.4M-$13.2M—
Gross margin93.4%93.0%100.0%——
Gross profit$0.3M$0.4M$0.1M——
Operating income-$15.6M-$11.6M-$15.1M-$18.9M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

BRTX · daily-25.9% over 13 sessions
Close EMA21 EMA50 EMA200
1.692.022.342.662.992026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$5M-$4M-$3M-$1M$0M-31432%-15668%97%2025-Q12025-Q22025-Q32025-Q42026-Q1